Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
06/05/1991 | EP0430709A2 Benzthiophen derivatives |
06/05/1991 | EP0430078A2 Steroids |
06/05/1991 | EP0430045A2 Ascorbic acid tocopheryl phosphate diesters for inhibition of Maillard's reaction |
06/05/1991 | EP0430029A2 Pyridin-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation and their use |
06/05/1991 | EP0429679A1 Potassium-supplementing preparation |
06/05/1991 | EP0429502A1 O-glycosylated igf-1 |
06/05/1991 | CN1051907A 24-homo-vitamin-0-derivatives, process for preparing them, pharmaceutical preparation containing them and use as pharmaceuticals |
06/05/1991 | CA2031376A1 Single layer transdermal drug administration system |
06/04/1991 | US5021570 Aqueous solution containing fat-soluble vitamin K |
06/04/1991 | US5021445 Hyperglycemic and hypertensive agents; anticoagulants, alpha2-adrenoceptor antagonists |
06/04/1991 | US5021239 Use of M-CSF to improve lipoprotein cholesterol profiles |
06/04/1991 | CA1284654C ¬4.2.0|bicyclooctane derivatives with valuable therapeutic properties |
05/31/1991 | WO1991008213A1 Oligoribonucloside and oligodeoxyribonucleoside boranophosphates |
05/31/1991 | CA2069905A1 Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
05/30/1991 | WO1991007373A1 New derivatives of 3,3,5-trimethylcyclohexanol methyl-2 propionate, preparation method and therapeutical compositions containing them |
05/30/1991 | WO1991007107A1 Oxazolidinedione hypoglycemic agents |
05/30/1991 | WO1991003226A3 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same |
05/29/1991 | EP0429370A1 Thiophene derivatives, process for their preparation and pharmaceutical compositions containing them |
05/29/1991 | EP0429360A2 Inhibition of withdrawal syndrome |
05/29/1991 | EP0429341A2 Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
05/29/1991 | EP0428608A1 Pharmaceutical and/or dietetic compositions containing l-carnitine and l-lysine |
05/29/1991 | DE4037708A1 Appetite suppressant contg. indirect sympathomimetic cpd. and tyrosine - has tyrosine and phenyl:propanolamine, amphetamine and/or ephedrine, which act with tyrosine |
05/29/1991 | CN1051733A Acat inhibitors |
05/29/1991 | CA2027815A1 Method and composition for decreasing appetite |
05/28/1991 | US5019594 Administring A Sympathomimetric Drug And Tyrosine |
05/28/1991 | US5019592 Aryloxyphenylpropylamines and their preparation and use |
05/28/1991 | US5019582 Piperidine compounds and their preparation and use |
05/28/1991 | CA2030720A1 Hexapeptides with sulphate ester groups |
05/28/1991 | CA1284497C Prodrugs of antihypercholesterolemic compounds |
05/25/1991 | WO1991008206A1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
05/25/1991 | CA2069423A1 Azacyclic derivatives |
05/24/1991 | CA2030633A1 Pyridine-2,4- and 2,5-dicarboxamides, a process for the preparation thereof, and the use thereof |
05/23/1991 | WO1991007188A1 Method for reducing blood cholesterol using arginine |
05/23/1991 | CA2069413A1 Method for reducing blood cholesterol using arginine |
05/23/1991 | CA2028759A1 Steroids |
05/22/1991 | WO1991007386A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
05/22/1991 | EP0428385A1 Cholesterol ester hydrolase inhibitors |
05/22/1991 | EP0428312A2 Oxazolidinedione hypoglycemic agents |
05/22/1991 | EP0428094A1 Mevinic acid derivatives |
05/22/1991 | EP0427779A1 Use of dextrin derivatives for the treatment of acidic conditions |
05/22/1991 | EP0427762A1 Substituted phenylacetonitriles used to overcome resistance to drugs in oncolytic therapy |
05/22/1991 | EP0427747A1 Substituted phenylacetonitriles used to overcome resistance to drugs in anti-malarial therapy. |
05/22/1991 | CN1051553A Acat inhibitors |
05/22/1991 | CN1051552A Acat inhibitors |
05/22/1991 | CA2069112A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
05/21/1991 | US5017700 Coenzyme |
05/21/1991 | US5017579 Use of aminoalkoxyphenyl derivatives for reducing and/or controlling excessive intraocular pressure |
05/21/1991 | US5017574 Novel imidazobenzodiazepines |
05/21/1991 | US5017572 Calcium antagonist |
05/21/1991 | CA2030238A1 Heterocyclic compounds, method for preparing thereof, and medications comprising them |
05/21/1991 | CA2029421A1 Pharmaceutical compositions and methods for inhibition of maillard's reaction |
05/21/1991 | CA1284333C ANTIHYPERCHOLESTEROLEMIC .beta.-LACTONES |
05/18/1991 | CA2030209A1 Therapeutic agents |
05/17/1991 | CA2030105A1 Acat inhibitors |
05/17/1991 | CA2030006A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin |
05/16/1991 | WO1991006294A1 Phosphate binders for oral prescriptions |
05/16/1991 | WO1990012879A3 Expression of human apolipoproteins ai-milano in yeast |
05/16/1991 | CA2029934A1 Cholesterol ester hydrolase inhibitors |
05/15/1991 | EP0427694A1 Synthesis of mannojirimycin derivatives |
05/15/1991 | EP0427480A1 2-Hydroxy-3-phenoxypropylamino compounds |
05/15/1991 | EP0427458A2 Use of heptapeptides in the treatment or prophylaxis of muscle wasting |
05/15/1991 | EP0427402A2 Treatment of shock by cyclodextrins and their derivatives |
05/15/1991 | EP0427162A1 Novel insulin derivatives, their preparation and use, and a pharmaceutical composition thereof |
05/15/1991 | EP0427026A2 Compositions for treating fat deposits in humans |
05/14/1991 | US5015661 Chromanes and their pharmaceutical compositions and methods |
05/14/1991 | US5015650 Circulation-active basic 4-aryl-DHP amides |
05/14/1991 | US5015644 Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
05/14/1991 | US5015642 Cardiovascular disorders and calcium antagonist |
05/08/1991 | EP0426098A1 Phosphate binding agent for oral administration |
05/08/1991 | EP0426066A2 Ace inhibitors for use for preventing onset of type II diabetes |
05/08/1991 | EP0425929A1 Process for the preparation of N-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxy-piperidine and of intermediates |
05/08/1991 | EP0425565A1 Silicon compounds in bone treatment. |
05/08/1991 | EP0425482A1 Human insulin analogs and preparations containing them. |
05/08/1991 | DE3935738A1 Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff A drug containing the human parathyroid hormone-fragment (1-37) as the active drug |
05/08/1991 | CN1051182A Polypeptides useful as blockers of calcium channels |
05/07/1991 | US5013749 Imidazole derivatives and their use as hypercholesterolemia and hyperlipoproteinemia agents |
05/07/1991 | US5013721 Anorexigenic and hypotensive peptides |
05/07/1991 | US5013718 Method for treating iron overload using EPO |
05/07/1991 | CA2029338A1 Acat inhibitors |
05/07/1991 | CA2029337A1 Acat inhibitors |
05/07/1991 | CA2029289A1 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them |
05/07/1991 | CA2029282A1 Chemical compounds |
05/04/1991 | CA2029268A1 Peptides aiding nerve regeneration |
05/02/1991 | WO1991005549A1 Benzoheterocyclic compounds |
05/02/1991 | EP0425109A2 3-Substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis |
05/02/1991 | EP0425096A1 Polypeptides useful as blockers of calcium channels |
05/02/1991 | EP0425066A1 Crystalline 2-0-alpha-D-glucopyranosyl-L-ascorbic acid, and its preparation and uses |
05/02/1991 | EP0424954A1 Pharmaceutical composition for treatment of osteoporosis |
05/02/1991 | EP0424929A1 Isoquinolone derivatives, their production and use |
05/02/1991 | EP0424385A1 Lipophilic polyamines useful for treating hypercholesterolemia |
05/01/1991 | CN1051038A Benzoheterocyclic compounds |
05/01/1991 | CA2026686A1 Method for preventing onset of type ii diabetes employing an ace inhibitor |
04/30/1991 | US5011952 Phospholipase A2 inhibitor |
04/30/1991 | US5011930 Antilipemic agents, anticoagulants |
04/30/1991 | US5011929 From protected azidolactone by reduction and cyclization |
04/30/1991 | US5011859 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase |
04/30/1991 | US5011848 Cardiovascular disorders, hypotensive agents |
04/30/1991 | US5011847 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists |
04/30/1991 | US5011840 Imidazolidinedione derivatives in diabetes treatment |
04/30/1991 | CA1283657C 1,5-benzothiazepine derivatives, their preparation and compositions containing them |